From armchair epidemiologists to armchair economists, never has society paid more attention to subject matter previously overlooked. With inflation persisting in the 6-6.5% range in 2022, market activity slowed considerably from 2021. From the same period a year ago, in 2H 2022 Health IT investment activity fell over 64% to $5.0 billion and M&A activity declined 35% to 139 transactions. Market…
Read More
2022 ushered in Act III of the market’s latest transitionary period: The Post-Inflation Era. To make sense of the crosscurrents from macroeconomic and inflation data, we leveraged our experience executing transactions, extensive network, and market analysis from our 16-year history advising and investing across the ever-evolving Health IT and Digital Health sectors to gather key market information.
Read More
The prevalence of mental and behavioral health conditions has been on the rise in recent decades, further aggravated by the pandemic in the last two years. Social isolation, grief from the loss of loved ones, fear of contracting the virus, and financial worries were all major stress factors that increasingly affected the mental wellbeing of the population, and the resulting statistics are startling:…
Read More
The US dental industry has seen a proliferation of new technologies, a trend driven by the rise of the consumeristic nature of dental care, which can be attributed to 3 key influences: 1) gaps in dental insurance coverage, 2) competitive pressures among private practices, and 3) the aggressive rollup of private equity-backed dental support organizations (DSOs). Self-pay and patient financial…
Read More
Despite the perception that valuations have risen in the post-pandemic era, the valuation tide has not lifted all boats equally. Following the pandemic, Health IT M&A valuations increased an impressive 36% from 5.1x revenue to 6.9x revenue. Meanwhile, the expanding universe of publicly traded Health IT, now 70 companies strong thanks to 35 recent IPO and SPAC transactions, contracted 16% in 2021…
Read More
In this post-pandemic era, the world is changing at a pace that is nearly impossible to process, which makes decision-making harder and seemingly riskier than ever. With limited data to inform our decisions and understanding of reality, instincts become crucial as we attempt to navigate and make sense of the world. So, let’s take a moment and unpack some of the data…
Read More
The digital health market is on fire. All things equal, based on our experience we estimate digital health valuations rose at least 30% from pre- to post-pandemic. For high performing companies, the valuation premium is much higher. Reinforcing our experience, from pre-pandemic February 2020 to post-pandemic June 2021, the NASDAQ rose 50%. Through June, M&A volume and value is on pace to increase…
Read More
Much like mental health, sexual health, and other conditions with social stigma, digestive health disorders cause many to suffer in silence. Only recently has society embraced a more public discussion of digestive health, ranging from wellness and performance to clinical prevention and chronic care management. A confluence of social acceptance, innovation, and worsening public health are…
Read More
Financial markets have recently experienced the rise of Special Purpose Acquisition Companies (SPACs). While these publicly traded investment vehicles have been around since the 1990s, a combination of key drivers have recently led to their increased popularity, launching them to the forefront of financial discussions. From the perspective…
Read More
Independent of the COVID-19 pandemic, the Biden administration was certain to prioritize healthcare reform within its agenda. In contrast to the previous administration’s attempts to repeal the Affordable Care Act, which came up short but resulted in the elimination of the Individual Mandate, President Biden and his administration is expected to support and build upon the Affordable Care Act as…
Read More